Genital Neoplasms, Female
"Genital Neoplasms, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
| Descriptor ID |
D005833
|
| MeSH Number(s) |
C04.588.945.418 C13.351.937.418
|
| Concept/Terms |
Genital Neoplasms, Female- Genital Neoplasms, Female
- Neoplasms, Female Genital
- Gynecologic Neoplasms
- Neoplasms, Gynecologic
- Gynecologic Neoplasm
- Neoplasm, Gynecologic
- Female Genital Neoplasms
- Female Genital Neoplasm
- Genital Neoplasm, Female
- Neoplasm, Female Genital
|
Below are MeSH descriptors whose meaning is more general than "Genital Neoplasms, Female".
Below are MeSH descriptors whose meaning is more specific than "Genital Neoplasms, Female".
This graph shows the total number of publications written about "Genital Neoplasms, Female" by people in this website by year, and whether "Genital Neoplasms, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genital Neoplasms, Female" by people in Profiles.
-
Williams KP, Lin CJ, Felix AS, Addison D, Sheppard VB, Sutton AL, Mumma MT, Im W, Juarez PD, Hood DB. The association between cardiovascular disease and breast and gynecologic cancers among black female patients. J Natl Med Assoc. 2023 Oct; 115(5):466-474.
-
Pattee K, Msadabwe S, Pfaendler K, Mupeta S, Lishimpi E, Zambezi W, Sinkala C, Chipampe M, Nteeni M, Jere S, Kalima-Munalula M, Kamfwa P, Mwanahamuntu M, Parham G, Zulu W, Njala B, Lombe D. The use a virtual interactive system to enhance gynecologic oncology multi-disciplinary care in Zambia. J Cancer Policy. 2021 09; 29:100298.
-
Chambers LM, Chalif J, Yao M, Chichura A, Morton M, Gruner M, Costales AB, Horowitz M, Chau DB, Vargas R, Rose PG, Michener CM, Debernardo R. Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol. 2021 08; 162(2):368-374.
-
Chambers LM, Michener CM, Rose PG, Reizes O, Yao M, Vargas R. Impact of antibiotic treatment on immunotherapy response in women with recurrent gynecologic cancer. Gynecol Oncol. 2021 04; 161(1):211-220.
-
Chambers LM, Costales AB, Crean-Tate K, Kuznicki M, Morton M, Horowitz M, Jagielo T, Rose PG, Michener C, Vargas R, Debernardo R. A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology. Gynecol Oncol. 2020 09; 158(3):794-802.
-
Harp D, Chowdhury I, Garcia-Barrio M, Welch C, Matthews R, Thompson W. Maintaining the reproductive potential of cancer patients during cancer treatment. Front Biosci (Schol Ed). 2014 01 01; 6(1):39-49.
-
Fernandez NP, Mulla ZD. Avoiding sparse data bias: an example from gynecologic oncology. J Registry Manag. 2012; 39(4):167-71.
-
Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors--a systematic review. Int J Psychiatry Med. 2010; 40(2):163-81.
-
Khorram O, Garthwaite M, Golos T. Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions. Mol Hum Reprod. 2002 Jan; 8(1):75-80.
-
Khorram O, Garthwaite M, Grosen E, Golos T. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril. 2001 Jan; 75(1):174-9.